Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atlas Venture Fund XI, L.P. Insider Profile
4 Followers
Atlas Venture Fund XI, L.P., Ten Percent Owner at Akero Therapeutics, holds 9.80M shares in Third Harmonic Bio, Inc. (Ticker: THRD), holds 6.56M shares in Dyne Therapeutics (Ticker: DYN), holds 2.75M shares in Xilio Therapeutics (Ticker: XLO).
Atlas Venture Fund XI, L.P. Akero Therapeutics (AKRO)Ten Percent Owner
Akero Therapeutics (AKRO)
Ten Percent Owner
Ranked #94,145 out of 99,335 Corporate Insiders
Profitable Transactions
1 out of 8 Profitable Transactions
Average Return
-46.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Atlas Venture Fund XI, L.P.'s holdings
Insider Roles
Roles that Atlas Venture Fund XI, L.P. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P.'s Trading History
Akero Therapeutics
Jan 02, 2020
Ten Percent Owner
Uninformative Sell
―
$84.44M
Dyne Therapeutics
Feb 28, 2024
Ten Percent Owner
Uninformative Sell
19.63M
$195.11M
Day One Biopharmaceuticals
Dec 14, 2022
Ten Percent Owner
Uninformative Sell
―
$80.15M
Xilio Therapeutics
Feb 09, 2024
Ten Percent Owner
Informative Sell
640.00
$2.53M
Ikena Oncology
Dec 14, 2021
Ten Percent Owner
Informative Sell
385.57K
$3.66M
Third Harmonic Bio, Inc.
Nov 05, 2024
Ten Percent Owner
Uninformative Sell
―
$112.19M
List of latest transactions for each holding click on a transaction to see Atlas Venture Fund XI, L.P.'s performance on stock
You May Also Like
Atlas Venture Fund XI, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Atlas Venture Fund XI, L.P.?
The percentage of profitable transactions made by Atlas Venture Fund XI, L.P. is 13%.
What is the average return per transaction made by Atlas Venture Fund XI, L.P.?
The average return per transaction made by Atlas Venture Fund XI, L.P. is -46.00%.
What stocks does Atlas Venture Fund XI, L.P. hold?
Atlas Venture Fund XI, L.P. holds: AKRO, DYN, DAWN, XLO, IKNA, THRD stocks.
What was Atlas Venture Fund XI, L.P.’s latest transaction?
Atlas Venture Fund XI, L.P. latest transaction was an Uninformative Sell of ―.
What was Atlas Venture Fund XI, L.P.'s most profitable transaction?
Atlas Venture Fund XI, L.P.’s most profitable transaction was an Informative Buy of AKRO stock on June 25, 2019. The return on the trade was 39.40%.
What is Atlas Venture Fund XI, L.P.'s role in Akero Therapeutics?
Atlas Venture Fund XI, L.P.'s role in Akero Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.